Citigroup Inc Ani Pharmaceuticals Inc Call Options Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIP
# of Institutions
211Shares Held
18.7MCall Options Held
11.7KPut Options Held
10.5K-
Black Rock Inc. New York, NY2.66MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$73.4 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY716KShares$39 Million0.01% of portfolio
-
State Street Corp Boston, MA704KShares$38.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$35.7 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $948M
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...